|
|
||||||||
ORIGINAL RESEARCH |
From the Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of South Florida College of Medicine, Tampa, Florida.
Objective: To find whether aspirin (acetylsalicylic acid, ASA) inhibits the growth of endometrial cancer cells in vitro in a way similar to that in colorectal cancer cells and to investigate the mechanisms by which aspirin might lead to growth inhibition.
Methods: Ishikawa human endometrial tumor cells were grown in the presence of ASA (15 mM) for 96 hours. Controls were treated with vehicle (absolute ethanol). Cell proliferation was assessed by 3-(4,5-dimethylthiazol-2-yl) -2,5-diphenyltetrazolium bromide assay. Apoptosis was determined by terminal deoxynucleotidyl transferasemediated dUTP nick-end labeling assay. Analysis of cell-cycle distribution and bcl-2 expression was assessed by flow cytometry.
Results: Acetylsalicylic acid induced a dose-dependent inhibition of Ishikawa cells in vitro. The percentage of growth inhibition was 2188% at concentrations of 15 mM. It also induced apoptosis and reduced bcl-2 expression in Ishikawa cells in a dose-dependent manner. Control cells and cells treated with the lowest concentration of ASA exhibited 2% apoptosis and more than 60% of the population expressed bcl-2. Apoptosis levels increased as levels of ASA increased from 2 to 5 mM (758%) with a concommitant decrease in bcl-2 expression from 46% at 2 mM to 2% at 5 mM. Acetylsalicylic acid concentrations of 3 mM or greater induced a shift from the resting phase (G0/G1) to S phase of the cell cycle.
Conclusion: Acetylsalicylic acid inhibited Ishikawa cell growth in vitro in a dose-dependent manner. Apoptosis is one of the mechanisms involved in the response, which can be mediated in part by downregulation of bcl-2.
This article has been cited by other articles:
![]() |
A. N. Viswanathan, D. Feskanich, E. S. Schernhammer, and S. E. Hankinson Aspirin, NSAID, and Acetaminophen Use and the Risk of Endometrial Cancer Cancer Res., April 1, 2008; 68(7): 2507 - 2513. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Modugno, R. B. Ness, C. Chen, and N. S. Weiss Inflammation and Endometrial Cancer: A Hypothesis Cancer Epidemiol. Biomarkers Prev., December 1, 2005; 14(12): 2840 - 2847. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. B. Moysich, J. A. Baker, K. J. Rodabaugh, and J. A. Villella Regular Analgesic Use and Risk of Endometrial Cancer Cancer Epidemiol. Biomarkers Prev., December 1, 2005; 14(12): 2923 - 2928. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. G. Drake and J. L. Becker Aspirin-Induced Inhibition of Ovarian Tumor Cell Growth Obstet. Gynecol., October 1, 2002; 100(4): 677 - 682. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |